Gilead Sciences to Present at the RBC Capital Markets 2017 Global Healthcare Conference on Wednesday, February 22

Wednesday, 8 February 2017
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced that John F. Milligan, PhD, Gilead’s President and Chief Executive Officer, and Robin L. Washington, Gilead’s Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the RBC Capital Markets 2017 Global Healthcare Conference in New York on Wednesday, February 22 at 9:30 a.m. Eastern Time. The audio portion of the fireside chat will be accessible live through the company’

Recent related news

Advertisement
Bernin, on June, 26 ^th 2017 *INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS* *AND SHARES FORMING THE SHARE CAPITAL* (Article L. 233-8 II of...
10 hours ago • GlobeNewswire
DEARBORN, Mich.--(BUSINESS WIRE)--Ford Motor Company (NYSE:F) will release its June 2017 U.S. sales results at approximately 9:15 a.m. EDT Monday, July 3, 2017....
6 hours ago • Business Wire
RIVERWOODS, Ill.--(BUSINESS WIRE)--Discover Financial Services (NYSE: DFS) plans to report its second quarter 2017 results after the market closes on Wednesday,...
6 hours ago • Business Wire
DUBLIN, June 26, 2017 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Glass Fiber Foundry Filter Market 2017-2021" report to their...
4 hours ago • FinanzNachrichten.de
Gilead Sciences executives provide some answers at the Goldman Sachs healthcare conference.
1 week ago • Motley Fool
US drugs giants Merck & Co Inc (NYSE:MRK) and Gilead Sciences Inc (NASDAQ:GILD) were among those to make large gains on Thursday following the release of the...
3 days ago • Proactive Investors

You might like